Really looking to see updated data before mid year? Enjoy the read! Hehehe!
$Aclarion (ACON.US)$ So CLARITY is expected to enroll up to 300 patients across approximately 8 sites with Nicholas Theodore, MD, FACS, FAANS, Director of the Neurosurgical Spine Center and Professor of Neurosurgery, Orthopedics, and Biomedical Engineering at Johns Hopkins, serving as principal investigator.
They have made great strides in advancing the clinical data supporting the utilization of Nociscan as a tool to improve surgical decisioning in spine surgery.
They have made great strides in advancing the clinical data supporting the utilization of Nociscan as a tool to improve surgical decisioning in spine surgery.
The CLARITY represents a pivotal study that could lead to national coverage decisions from every payer of significance, if CLARITY results confirm those from existing peer reviewed published data. Since Nociscan is a diagnostic, it shiuld quickly and cost effectively demonstrate the value of the technology in comparison to the costly and lengthy clinical trials typical for implantable devices that are mostly used today.
The Company is also advancing through the first phases of the Alphatec strategic partnership. Aclarion and Alphatec leadership are in the process of identifying 5 KOL surgeons who are currently using Alphatec's AlphaInformatiX platform and want to add Nociscan data to their preprocedural planning and surgical decisioning process. The Company expects to add 5 new KOLs to the Nociscan network in the first half of 2024.
As they continue to add imaging centers to meet the needs of the core panel of 10 KOLs, and working with Alphatec to add an additional 5 KOLs to the Aclarion network. Due to the large number of surgeons driving Alphatec growth, they are building their new KOL panel with surgeons who already have access to an imaging center capable of performing Nociscans. This will greatly accelerate the ability to reap the benefits of surgeon feedback and accelerate not only Nociscan utilization but should speed up the sequential steps of the strategic partnership? ((( One can hope, right )))
The Company will provide updates as clinical sites are added to CLARITY and KOLs partnership.![]()
The Company is also advancing through the first phases of the Alphatec strategic partnership. Aclarion and Alphatec leadership are in the process of identifying 5 KOL surgeons who are currently using Alphatec's AlphaInformatiX platform and want to add Nociscan data to their preprocedural planning and surgical decisioning process. The Company expects to add 5 new KOLs to the Nociscan network in the first half of 2024.
As they continue to add imaging centers to meet the needs of the core panel of 10 KOLs, and working with Alphatec to add an additional 5 KOLs to the Aclarion network. Due to the large number of surgeons driving Alphatec growth, they are building their new KOL panel with surgeons who already have access to an imaging center capable of performing Nociscans. This will greatly accelerate the ability to reap the benefits of surgeon feedback and accelerate not only Nociscan utilization but should speed up the sequential steps of the strategic partnership? ((( One can hope, right )))
The Company will provide updates as clinical sites are added to CLARITY and KOLs partnership.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
MikeyMikeMike : I see a gap that need filled.
Trytosaveabit OP MikeyMikeMike : Why yes! If you’re talking about the big ole gap on the daily left by the offering crash? You would be correct and probably thinking it could be a bit juicy! Hehehe
MikeyMikeMike Trytosaveabit OP : Also 300 CBT and only 10k LTB
MikeyMikeMike MikeyMikeMike : See if I can pull some out at 0.34
Trytosaveabit OP MikeyMikeMike : GL
Rockhoundj : I bought 100 just for shitz and giggles
Trytosaveabit OP Rockhoundj : Nice! GL and big profits to ya!
MikeyMikeMike : investorplace.c...